Mackenzie Financial Corp Purchases 5,688 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mackenzie Financial Corp boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 129,972 shares of the company's stock after buying an additional 5,688 shares during the period. Mackenzie Financial Corp owned approximately 0.05% of HCA Healthcare worth $39,011,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of HCA. Forum Financial Management LP increased its holdings in HCA Healthcare by 5.2% during the fourth quarter. Forum Financial Management LP now owns 1,033 shares of the company's stock worth $310,000 after buying an additional 51 shares during the last quarter. Toronto Dominion Bank increased its holdings in HCA Healthcare by 134.5% during the fourth quarter. Toronto Dominion Bank now owns 226,811 shares of the company's stock worth $68,076,000 after buying an additional 130,076 shares during the last quarter. GF Fund Management CO. LTD. acquired a new position in HCA Healthcare during the fourth quarter worth $1,395,000. University of Texas Texas AM Investment Management Co. increased its holdings in HCA Healthcare by 56.7% during the fourth quarter. University of Texas Texas AM Investment Management Co. now owns 7,315 shares of the company's stock worth $2,196,000 after buying an additional 2,646 shares during the last quarter. Finally, Public Employees Retirement System of Ohio bought a new position in HCA Healthcare during the fourth quarter worth $25,674,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Trading Down 0.1%

Shares of HCA Healthcare stock traded down $0.46 on Wednesday, hitting $378.35. The stock had a trading volume of 921,090 shares, compared to its average volume of 1,440,369. The stock has a 50 day moving average of $348.50 and a 200 day moving average of $329.62. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market capitalization of $91.02 billion, a P/E ratio of 17.22, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the firm posted $5.36 earnings per share. The firm's revenue was up 5.7% compared to the same quarter last year. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Guggenheim started coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Robert W. Baird reissued a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $381.13.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.